Reactive Oxygen Species Scavenging Nanomedicine for The Treatment of Ischemic Heart Disease
Zhan Zhang,Rinkoo Dalan,Zhenyu Hu,Jiong‐Wei Wang,Nicholas WS Chew,Kian‐Keong Poh,Ru‐San Tan,Tuck Wah Soong,Yunlu Dai,Lei Ye,Xiaoyuan Chen
DOI: https://doi.org/10.1002/adma.202202169
IF: 29.4
2022-04-25
Advanced Materials
Abstract:Ischemic heart disease (IHD) is the leading cause of disability and mortality worldwide. Reactive oxygen species (ROS) have been shown to play key roles in the progression of diabetes, hypertension, and hypercholesterolemia which are independent risk factors that lead to atherosclerosis and the development of IHD. Engineered biomaterial‐based nanomedicines are under extensive investigation and exploration, serving as smart and multifunctional nanocarriers for synergistic therapeutic effect. Capitalizing on the cell/molecule‐targeting drug delivery, nanomedicines present enhanced specificity and safety with favorable pharmacokinetics and pharmacodynamics. In this review, we focus on introducing the roles of ROS in both IHD and its risk factors, highlighting cardiovascular medications that have antioxidant properties, summarizing the advantages, properties, and recent achievements of nanomedicines that have the ROS scavenging capacity for the treatment of diabetes, hypertension, hypercholesterolemia, atherosclerosis, ischemia/reperfusion, and myocardial infarction. Finally, this review will discuss the current challenges of nanomedicines for ROS scavenging treatment of IHD and possible future directions from a clinical perspective.This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology